Beth Adams Norton

USPTO Granted Patents = 13 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 30(Granted Patents)

Location History:

Research Triangle Park, NC (US) (2010 - 2013)
Collegeville, PA (US) (2013)
Del Mar, CA (US) (2014)
Durham, NC (US) (2010 - 2017)

Company Filing History:

Janssen Pharmaceuticals, Inc.

Anacor Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2010-2017

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9814699 - Chemical compounds (2017-11-14),

2. 9163024 - Tris salts of 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione (2015-10-20),

3. 9150587 - Chemical compounds (2015-10-06),

4. 8859550 - Heterocyclic inhibitors of histamine receptors for the treatment of disease (2014-10-14),

5. 8853416 - Chemical compounds (2014-10-07),

6. 8492554 - Chemical compounds (2013-07-23),

7. 8461364 - Polymorphs of (S)-3-aminomethyl-7-(3-hydroxy-propoxy)-3H-benzo[C][1,2]oxaborol-1-OL (2013-06-11),

8. 8354416 - 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase (2013-01-15),

9. 8344155 - Chemical compounds (2013-01-01),

10. 8207176 - Compounds (2012-06-26),

11. 7893056 - Peptide deformylase inhibitors (2011-02-22),

12. 7678801 - Compounds (2010-03-16),

13. 7674792 - 5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one (2010-03-09),

Title: The Innovative Contributions of Beth Adams Norton

Introduction

Beth Adams Norton is an accomplished inventor based in Durham, North Carolina. With an impressive portfolio of 13 patents, her work primarily focuses on the development of chemical compounds with significant therapeutic applications. Norton's innovative approaches have contributed to advancements in pharmaceutical technology and treatment methodologies.

Latest Patents

Among her latest patents, Norton has disclosed several noteworthy compounds. One patent details compounds of Formula III, which includes their salts and pharmaceutical compositions aimed at treating HCV infection through administration of these compounds. Additionally, she has developed a tris salt of 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione. This patent outlines corresponding pharmaceutical formulations, manufacturing processes, and therapeutic uses, particularly in conditions where the under-activation of the HM74A receptor is involved.

Career Highlights

Throughout her career, Beth Adams Norton has made a significant impact in the pharmaceutical industry. She has held positions at renowned companies, including GlaxoSmithKline LLC and Janssen Pharmaceuticals, Inc. Her work in these organizations highlights her commitment to innovation and the development of vital medical solutions.

Collaborations

Collaboration has played a key role in Norton's achievements. She has worked alongside esteemed colleagues such as Pingyun Chen and Ricky Wayne Couch. These partnerships have facilitated the exchange of ideas and expertise, leading to groundbreaking developments in her field.

Conclusion

Beth Adams Norton exemplifies the spirit of innovation and dedication in the pharmaceutical sector. With her extensive patent portfolio and collaborative efforts, she continues to pave the way for future advancements in medical treatments. Her contributions not only reflect her ingenuity but also play a vital role in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.